Deciphering the cellular landscape and potential targets of nasopharyngeal and oral cancers using single‐cell RNA sequencing
Y Zhang, X Qin, W Lou, L Wang, W Lu… - Cell Biology …, 2024 - Wiley Online Library
Cellular heterogeneity in nasopharyngeal cancer (NPC) and oral cancer remains unclear. In
the current study, using single‐cell RNA sequencing techniques, we investigated the cellular …
the current study, using single‐cell RNA sequencing techniques, we investigated the cellular …
Quality Assurance in Radiotherapy (RT)-Specific Trials: Indian Scenario
A Mahata, S Chakraborty, S Mandal, RB Achari… - Clinical Oncology, 2024 - Elsevier
Aims There is evidence that proper radiotherapy trial quality assurance (RTTQA) translates
into improved outcomes for patients. However, the practice of RTTQA is heterogeneous and …
into improved outcomes for patients. However, the practice of RTTQA is heterogeneous and …
[HTML][HTML] Long-term Prospective Comparative Analysis of Ototoxic and Survival Outcomes of Sequential Boost and Simultaneous Integrated Boost of Volumetric …
N Das, SH Kombathula, V Sharma… - Turkish Archives of …, 2025 - pmc.ncbi.nlm.nih.gov
Objective To compare the ototoxicity and survival in head and neck carcinoma patients
treated with sequential (SEQ) and simultaneous integrated boost (SIB) of volumetric …
treated with sequential (SEQ) and simultaneous integrated boost (SIB) of volumetric …
Tolerability and Efficacy of Simultaneously Integrated Boost Radiotherapy in Head and Neck Cancer Treatment
G Kelemen, E Fodor, K Hideghéty, M Csenki… - Available at SSRN … - papers.ssrn.com
This study included patients with head and neck cancers who received definitive or
postoperative radiotherapy (RT) between September 2022 and October 2023 at the …
postoperative radiotherapy (RT) between September 2022 and October 2023 at the …